1. Home
  2. SBS vs RVMD Comparison

SBS vs RVMD Comparison

Compare SBS & RVMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Companhia de saneamento Basico

SBS

Companhia de saneamento Basico

HOLD

Current Price

$34.17

Market Cap

21.2B

Sector

Utilities

ML Signal

HOLD

Logo Revolution Medicines Inc.

RVMD

Revolution Medicines Inc.

HOLD

Current Price

$95.68

Market Cap

19.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SBS
RVMD
Founded
1954
2014
Country
Brazil
United States
Employees
N/A
883
Industry
Water Supply
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
21.2B
19.2B
IPO Year
2002
N/A

Fundamental Metrics

Financial Performance
Metric
SBS
RVMD
Price
$34.17
$95.68
Analyst Decision
Strong Buy
Analyst Count
0
17
Target Price
N/A
$120.47
AVG Volume (30 Days)
1.3M
1.6M
Earning Date
05-11-2026
05-06-2026
Dividend Yield
1.39%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$16.25
$411.49
P/E Ratio
$15.19
N/A
Revenue Growth
N/A
N/A
52 Week Low
$18.09
$34.00
52 Week High
$33.14
$124.49

Technical Indicators

Market Signals
Indicator
SBS
RVMD
Relative Strength Index (RSI) 73.91 46.63
Support Level $23.76 $93.39
Resistance Level N/A $101.00
Average True Range (ATR) 0.76 3.06
MACD 0.44 0.17
Stochastic Oscillator 99.31 44.15

Price Performance

Historical Comparison
SBS
RVMD

About SBS Companhia de saneamento Basico

Companhia De Saneamento Basico Do Estado De Sao Paulo is engaged in the provision of basic and environmental sanitation services in Sao Paulo State, and supplies treated water and sewage services on a wholesale basis. SABESP may perform activities in other states and countries and can operate in drainage, urban cleaning, solid waste handling, and energy markets. The company determined that it has a single operating segment, which is the provision of sanitation services.

About RVMD Revolution Medicines Inc.

Revolution Medicines Inc is a clinical-stage precision oncology company developing novel targeted therapies for RAS-addicted cancers. The Company possesses structure-based drug discovery capabilities built upon chemical biology and cancer pharmacology know-how and proprietary technologies that enable the creation of small molecules tailored to unconventional binding sites. Its research and development pipeline comprises inhibitors that bind directly to RAS variants (RAS(ON) Inhibitors), designed to be used as monotherapy, in combination with other RAS(ON) Inhibitors and/or other therapeutic agents.

Share on Social Networks: